Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration

Objectives To report demographics, regional variations, and indications for preexposure prophylaxis (PrEP) use for HIV prevention in the Veterans Health Administration (VHA). Methods We identified persons initiating tenofovir/emtricitabine for the PrEP indication in the United States between July 2012 and April 2016 in a VHA national database. We stratified PrEP use by provider type and VHA region. We calculated PrEP initiation rate for each region with VHA population data. Results Of the 825 persons who initiated PrEP during the observation period, 67% were White and 76% were men who have sex with men. People who inject drugs and transgender persons represented less than 1% each of the cohort. The majority of PrEP initiations were clustered in 3 states, leading with California (28%) followed by Florida (9%) and Texas (8%). The Southeast had one of the lowest PrEP rates at 10 PrEP initiations per 100 000 persons in care. Infectious disease specialists issued more than two thirds of index PrEP prescriptions. Conclusions Uptake of PrEP in the VHA is uneven along geographic and risk categories. Understanding the reasons behind these gaps will be key in expanding the use of this important prevention tool.

[1]  G. Samsa,et al.  An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. , 2018, AIDS care.

[2]  M. Vaughan-Sarrazin,et al.  Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-exposure Prophylaxis (PrEP) to Prevent HIV Infection , 2017, Journal of acquired immune deficiency syndromes.

[3]  A. Martinez-Donate,et al.  An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users , 2017, Sexually transmitted diseases.

[4]  S. Back,et al.  Substance use disorders in military veterans: prevalence and treatment challenges , 2017, Substance abuse and rehabilitation.

[5]  K. Mayer,et al.  Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts , 2017, AIDS care.

[6]  K. Whetten,et al.  State of HIV in the US Deep South , 2017, Journal of Community Health.

[7]  K. Fujimoto,et al.  Use of Pre-exposure Prophylaxis (PrEP) in Young Men Who Have Sex with Men is Associated with Race, Sexual Risk Behavior and Peer Network Size , 2017, AIDS and Behavior.

[8]  V. Patel,et al.  Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic , 2017, AIDS care.

[9]  Aerielle M. Allen,et al.  Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men , 2017, AIDS and Behavior.

[10]  D. Smith,et al.  Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons—United States, 2010–2014 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Sullivan,et al.  Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia , 2016, International journal of STD & AIDS.

[12]  V. Patel,et al.  Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York , 2017, AIDS and Behavior.

[13]  J. Parsons,et al.  Exploring Patterns of Awareness and Use of HIV Pre-Exposure Prophylaxis Among Young Men Who Have Sex with Men , 2017, AIDS and Behavior.

[14]  L. Koenig,et al.  Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States. , 2016, MMWR. Morbidity and mortality weekly report.

[15]  J. Volk,et al.  Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System. , 2016, American journal of public health.

[16]  Kenneth T. Jones,et al.  Mental Health and Medical Health Disparities in 5135 Transgender Veterans Receiving Healthcare in the Veterans Health Administration: A Case-Control Study. , 2016, LGBT health.

[17]  John A. Guidry,et al.  A Clinical Home for Preexposure Prophylaxis , 2016, Journal of the International Association of Providers of AIDS Care.

[18]  V. Patel,et al.  A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians , 2016, Journal of General Internal Medicine.

[19]  R. Wolitski,et al.  Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. , 2015, MMWR. Morbidity and mortality weekly report.

[20]  Philip J. Peters,et al.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[21]  J. Lindsay,et al.  Access to care for transgender veterans in the Veterans Health Administration: 2006-2013. , 2014, American journal of public health.

[22]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[23]  K. Gamarel,et al.  From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. , 2013, AIDS patient care and STDs.

[24]  C. Beyrer,et al.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[25]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[26]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[27]  J. Stockman,et al.  Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men , 2012 .

[28]  R. Valdiserri,et al.  National quality forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experience. , 2010, Archives of internal medicine.